PROM1 and neoplasm: So, the tumor inhibited effects of BMPR-IB in our study are on those glioblstoma cells that express a low level of BMPR-IB, but are not limited to the fraction of cells with a stem cell-like phenotype (CD133+ cells) as reported by Piccirllo.